Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

DP. McLornan, R. Szydlo, M. Robin, A. van Biezen, L. Koster, HJP. Blok, MT. Van Lint, J. Finke, A. Vitek, K. Carlson, L. Griskevicius, E. Holler, M. Itälä-Remes, M. Schaap, G. Socié, JO. Bay, Y. Beguin, B. Bruno, JJ. Cornelissen, T. Gedde-Dahl,...

. 2018 ; 182 (3) : 418-422. [pub] 20180529

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028409

Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.

A O U Citta della Salute e della Scienza di Torino S S C 5 D Trapianto di Cellule Staminali Torino Italy

CHU de Lille LIRIC INSERM U995 Universite de Lille Lille France

Clinic for Cancer Surgery and Transplantation Oslo University Hospital Rikshospitalet Norway

Comprehensive Cancer Centre Division of Haematology King's College London

Department of Haematology and Oncology University of Regensburg Regensburg Germany

Department of Haematology Hopital d`Enfants Nancy France

Department of Haematology Karolinska University Hospital Stockholm Sweden

Department of Haematology Radboud University Medical Centre Nijmegen the Netherlands

Department of Haematology University of Liege Liege Belgium

Division of Haematology Geneva University Hospitals Geneva Switzerland

EBMT Data Office University Medical Centre Leiden the Netherlands

Erasmus MC Cancer Institute University Medical Centre Rotterdam the Netherlands

Haematology Oncology and Transfusion Centre Vilnius University Hospital Santaros Klinikos Vilnius Lithuania

Hammersmith Hospital NHS Foundation Trust London United Kingdom

Institute of Haematology and Blood Transfusion Prague Czech Republic

Ospedale San Martino Genova Italy

Service d'hématologie clinique Adulte et pédiatrie CHU ESTAING Clermont France

Service d'Hématologie Greffe Hôpital Saint Louis Assistance Publique Hôpitaux de Paris Paris France

Stem Cell Transplant Unit Turku University Hospital Turku Finland

University Hospital Eppendorf Hamburg Germany

University Hospital Uppsala Uppsala Sweden

University of Freiburg Freiburg Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028409
003      
CZ-PrNML
005      
20190822083354.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bjh.15407 $2 doi
035    __
$a (PubMed)29808926
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a McLornan, Donal P $u Comprehensive Cancer Centre, Division of Haematology, King's College, London.
245    10
$a Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT / $c DP. McLornan, R. Szydlo, M. Robin, A. van Biezen, L. Koster, HJP. Blok, MT. Van Lint, J. Finke, A. Vitek, K. Carlson, L. Griskevicius, E. Holler, M. Itälä-Remes, M. Schaap, G. Socié, JO. Bay, Y. Beguin, B. Bruno, JJ. Cornelissen, T. Gedde-Dahl, P. Ljungman, MT. Rubio, I. Yakoub-Agha, E. Klyuchnikov, E. Olavarria, Y. Chalandon, N. Kröger,
520    9_
$a Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.
650    _2
$a dospělí $7 D000328
650    _2
$a management nemoci $7 D019468
650    _2
$a farmakoterapie $7 D004358
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a transplantace hematopoetických kmenových buněk $x metody $7 D018380
650    _2
$a lidé $7 D006801
650    _2
$a transfuze lymfocytů $7 D017710
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a primární myelofibróza $x mortalita $x terapie $7 D055728
650    _2
$a recidiva $7 D012008
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a analýza přežití $7 D016019
650    _2
$a homologní transplantace $7 D014184
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Szydlo, Richard $u Hammersmith Hospital NHS Foundation Trust, London, United Kingdom.
700    1_
$a Robin, Marie $u Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
700    1_
$a van Biezen, Anja $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
700    1_
$a Koster, Linda $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
700    1_
$a Blok, Henrik J P $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
700    1_
$a Van Lint, Maria T $u Ospedale San Martino, Genova, Italy.
700    1_
$a Finke, Jürgen $u University of Freiburg, Freiburg, Germany.
700    1_
$a Vitek, Antonin $u Institute of Haematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Carlson, Kristina $u University Hospital Uppsala, Uppsala, Sweden.
700    1_
$a Griskevicius, Laimonas $u Haematology, Oncology& Transfusion Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
700    1_
$a Holler, Ernst $u Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany.
700    1_
$a Itälä-Remes, Maija $u Stem Cell Transplant Unit, Turku University Hospital, Turku, Finland.
700    1_
$a Schaap, Michel $u Department of Haematology, Radboud University Medical Centre, Nijmegen, the Netherlands.
700    1_
$a Socié, Gerard $u Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
700    1_
$a Bay, Jacques-Olivier $u Service d'hématologie clinique Adulte et pédiatrie, CHU ESTAING, Clermont, France.
700    1_
$a Beguin, Yves $u Department of Haematology, University of Liege, Liege, Belgium.
700    1_
$a Bruno, Benedetto $u A.O.U Citta della Salute e della Scienza di Torino, S.S.C.V.D Trapianto di Cellule Staminali, Torino, Italy.
700    1_
$a Cornelissen, Jan J $u Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.
700    1_
$a Gedde-Dahl, Tobias $u Clinic for Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
700    1_
$a Ljungman, Per $u Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Rubio, Marie T $u Department of Haematology, Hopital d`Enfants, Nancy, France.
700    1_
$a Yakoub-Agha, Ibrahim $u CHU de Lille, LIRIC, INSERM U995, Universite de Lille, Lille, France.
700    1_
$a Klyuchnikov, Evgeny $u University Hospital Eppendorf, Hamburg, Germany.
700    1_
$a Olavarria, Eduardo $u Hammersmith Hospital NHS Foundation Trust, London, United Kingdom.
700    1_
$a Chalandon, Yves $u Division of Haematology, Geneva University Hospitals, Geneva, Switzerland.
700    1_
$a Kröger, Nicolaus $u University Hospital Eppendorf, Hamburg, Germany.
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 182, č. 3 (2018), s. 418-422
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29808926 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822083632 $b ABA008
999    __
$a ok $b bmc $g 1433558 $s 1066869
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 182 $c 3 $d 418-422 $e 20180529 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace